Signal transduction pathway activity in adult-type granulosa cell tumor samples

G. J. Brink*, J. W. Groeneweg, P. van der Ploeg, G. N. Jonges, E. H. Gort, P. O. Witteveen, R. P. Zweemer, J. M.J. Piek

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Abstract

Objective: This study aims to evaluate signal transduction pathway (STP) activity in adult-type granulosa cell tumors (aGCT) in order to identify potential therapeutic targets. These results are compared with STP activity in healthy ovarian tissue and low and high grade serous ovarian carcinoma (LGSC and HGSC). Methods: STP activity was assessed by a RNA-based assay for the following oncogenic pathways: Hedhehog (HH), transforming growth factor beta (TGF-β), Notch, phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinase (MAPK), androgen receptor (AR) and estrogen receptor (ER). Results: Samples of 31 aGCTs and a healthy granulosa cell were included and compared with 24 LGSC and 50 HGSC samples. In aGCT, significantly higher activity of the HH, Notch, PI3K and ER pathways was found, as compared to healthy granulosa cells. When compared with LGSC and HGSC, aGCT exhibited significantly higher PI3K pathway activity and lower HH, TGF-β, Notch, MAPK, AR, and ER pathway activity. Conclusions: Our results show high PI3K pathway activity in aGCT samples. Pathway activity contrasts with findings in both healthy granulosa cells and serous ovarian carcinoma. Therefore, the PI3K pathway may be a target for treatment, specifically for aGCT patients.

Original languageEnglish
Pages (from-to)6-11
Number of pages6
JournalGynecologic Oncology
Volume195
DOIs
Publication statusPublished - Apr 2025

Keywords

  • Granulosa cell tumor
  • PI3K pathway
  • Serous ovarian carcinoma
  • Signal transduction pathway

Fingerprint

Dive into the research topics of 'Signal transduction pathway activity in adult-type granulosa cell tumor samples'. Together they form a unique fingerprint.

Cite this